Product Description: Rociletinib (CO-1686) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.
Applications: Cancer-Kinase/protease
Formula: C27H28F3N7O3
References: [1]Walter AO, et al. Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC. Cancer Discov. 2013 Sep 25.
CAS Number: 1374640-70-6
Molecular Weight: 555.55
Compound Purity: 99.79
Research Area: Cancer
Solubility: DMSO : 125 mg/mL (ultrasonic;warming;heat to 60°C)